Healio

Tertiary care center reports more NAION cases during COVID-19 pandemic

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. More cases of acute nonarteritic anterior ischemic optic ...
Healio

Tertiary care center providers prescribe ‘select agents’ in asthma inhalers

Please provide your email address to receive an email when new articles are posted on . For mild to moderate asthma, many providers reported prescribing a 110 µg/actuation fluticasone metered dose ...
The American Journal of Managed Care

Specialty Tertiary Care for CRSwNP Significantly Improves Patient Outcomes

Dupilumab treatment delivered at a specialized tertiary care center has great potential to improve patient clinical outcomes in chronic rhinosinusitis with nasal polyps (CRSwNP). The mean (SD) ...
ascopubs.org

Evaluation of hematology/oncology patient and physician expectations for integrative oncology at a tertiary care center.

Update analysis: Prospective observational study for the impact of short-term periodic steroid premedication for cancer chemotherapy on bone metabolism—ESPRESSO-01 study. This is an ASCO Meeting ...
ascopubs.org

Using a European Value-Based Medicine Approach to Evaluate Hepatocellular Carcinoma Care at a US Tertiary Care Center.

The effect of demographics and socio-economic factors on survival in unresectable intrahepatic cholangiocarcinoma: A Surveillance, Epidemiology and End Results (SEER) population study. This is an ASCO ...
Nature

A retrospective comparison of VLBW outcomes before and after implementing new delivery room guidelines at a regional tertiary care center

To evaluate the impact of implemented protocol changes on delivery room interventions and very low birth weight (VLBW) health outcomes. In response to evolving national standards of care, The Children ...
The American Journal of Managed Care

Integrating CAR T-Cell Therapy and Bispecific Antibodies Into Hematologic Malignancy Care: Anita D’Souza, MD

Chimeric antigen receptor (CAR) T-cell therapy and bispecific antibodies are transforming multiple myeloma care, with earlier use, expanded community access, and outpatient delivery models offering ...